Handbook of Bioequivalence Testing
As the generic pharmaceutical industry continues to grow and thrive, so does the need to conduct adequate, efficient bioequivalence studies. In recent years, there have been significant changes to the statistical models for evaluating bioequivalence. In addition, advances in the analytical technology used to detect drug and metabolite levels have m
CHF 219.30
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-1-4822-2638-6
- EAN: 9781482226386
- Produktnummer: 31850049
- Verlag: Taylor & Francis Ltd.
- Sprache: Englisch
- Erscheinungsjahr: 2014
- Seitenangabe: 1007 S.
- Plattform: PDF
- Masse: 12'394 KB
- Auflage: 2. Auflage
Über den Autor
Sarfaraz K. Niazi, PhD, is the chairman and CEO of Therapeutic Proteins International, a world-class developer and manufacturer of biosimilar recombinant drugs. The company now leads the world in using innovative methods of manufacturing biosimilar recombinant drugs coming off-patents. He employs hundreds of world's top scientists working toward the goal of making life-saving biological drugs more affordable. He has published over 100 refereed research articles and abstracts, dozens of books, and hundreds of literary writings that span the vast areas of poetry, philosophy, rhetoric, irony, and modern dilemma.
59 weitere Werke von Sarfaraz K. Niazi:
Handbook of Pharmaceutical Manufacturing Formulations, Third Edition
Ebook (EPUB Format)
CHF 1,175.20
Handbook of Pharmaceutical Manufacturing Formulations, Third Edition
Ebook (PDF Format)
CHF 1,175.20
Bewertungen
Anmelden